BrightSpring Health Services reports Q3 2026 revenue up 26.4%, raises full-year guidance.

BrightSpring Health Services announced a 26.4% increase in net revenue for Q3 2026 to $4.213 billion, driven by growth in its Pharmacy and Provider segments. Adjusted EBITDA rose 42% to $228 million, reflecting strong operational execution. The company raised its full-year 2026 revenue guidance to $15.9-$16.125 billion and adjusted EBITDA guidance to $850-$860 million, signaling confidence in continued growth. This positions BrightSpring well for durable growth in 2027 and beyond.

BrightSpring Health Services holds a market cap of $11.94 billion on Pluang as of Oct 30, 2026, 17:11 WIB, with a strong buying interest reflected in 90% buy orders. The stock price rose 7.24% in one day to USD 64.58, showing positive momentum following its upbeat financial results and raised guidance. Trading volume reached nearly 4 million shares, indicating active investor engagement.